{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:15:31Z","timestamp":1783350931076,"version":"3.54.6"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T00:00:00Z","timestamp":1301961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1038\/nrrheum.2011.39","type":"journal-article","created":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T12:23:50Z","timestamp":1302092630000},"page":"297-306","source":"Crossref","is-referenced-by-count":121,"title":["Pathogenesis, classification and treatment of inflammatory myopathies"],"prefix":"10.1038","volume":"7","author":[{"given":"Mei","family":"Zong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,5]]},"reference":[{"key":"BFnrrheum201139_CR1","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas, M. C. Polymyositis, dermatomyositis and inclusion-body myositis. N. Engl. J. Med. 325, 1487\u20131498 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201139_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas, M. C. & Hohlfeld, R. Polymyositis and dermatomyositis. Lancet 362, 971\u2013982 (2003).","journal-title":"Lancet"},{"key":"BFnrrheum201139_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.7326\/0003-4819-111-2-143","volume":"111","author":"PH Plotz","year":"1989","unstructured":"Plotz, P. H. et al. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann. Intern. Med. 111, 143\u2013157 (1989).","journal-title":"Ann. Intern. Med."},{"key":"BFnrrheum201139_CR4","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2353\/ajpath.2009.090196","volume":"175","author":"CK Li","year":"2009","unstructured":"Li, C. K. et al. Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis. Am. J. Pathol. 175, 1030\u20131040 (2009).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201139_CR5","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju, K. et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 52, 1824\u20131835 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR6","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1212\/01.wnl.0000192128.13875.1e","volume":"66","author":"V Askanas","year":"2006","unstructured":"Askanas, V. & Engel, W. K. Inclusion-body myositis: a myodegenerative conformational disorder associated with A\u03b2, protein misfolding, and proteasome inhibition. Neurology 66, S39\u2013S48 (2006).","journal-title":"Neurology"},{"key":"BFnrrheum201139_CR7","doi-asserted-by":"publisher","first-page":"b2680","DOI":"10.1136\/bmj.b2680","volume":"339","author":"SA Greenberg","year":"2009","unstructured":"Greenberg, S. A. How citation distortions create unfounded authority: analysis of a citation network. BMJ 339, b2680 (2009).","journal-title":"BMJ"},{"key":"BFnrrheum201139_CR8","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.27572","volume":"62","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine, L. et al. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 62, 2757\u20132766 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR9","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1136\/ard.2006.052191","volume":"65","author":"GJ Hengstman","year":"2006","unstructured":"Hengstman, G. J. et al. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann. Rheum. Dis. 65, 1635\u20131638 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201139_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/BOR.0b013e3283157538","volume":"20","author":"CM de Padilla","year":"2008","unstructured":"de Padilla, C. M. & Reed, A. M. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies. Curr. Opin. Rheumatol. 20, 669\u2013674 (2008).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201139_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11926-009-0041-1","volume":"11","author":"AM Reed","year":"2009","unstructured":"Reed, A. M. & Ernste, F. The inflammatory milieu in idiopathic inflammatory myositis. Curr. Rheumatol. Rep. 11, 295\u2013301 (2009).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrrheum201139_CR12","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1093\/rheumatology\/keq151","volume":"49","author":"P Szodoray","year":"2010","unstructured":"Szodoray, P. et al. Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand. Rheumatology (Oxford) 49, 1867\u20131877 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201139_CR13","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0002-9440(10)62513-8","volume":"159","author":"P Englund","year":"2001","unstructured":"Englund, P., Lindroos, E., Nennesmo, I., Klareskog, L. & Lundberg, I. E. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Am. J. Pathol. 159, 1263\u20131273 (2001).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201139_CR14","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.4049\/jimmunol.161.11.5943","volume":"161","author":"L Behrens","year":"1998","unstructured":"Behrens, L. et al. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. J. Immunol. 161, 5943\u20135951 (1998).","journal-title":"J. Immunol."},{"key":"BFnrrheum201139_CR15","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1073\/pnas.0236183100","volume":"100","author":"M Hofbauer","year":"2003","unstructured":"Hofbauer, M. et al. Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis. Proc. Natl Acad. Sci. USA 100, 4090\u20134095 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201139_CR16","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.4049\/jimmunol.0803688","volume":"183","author":"AE Fasth","year":"2009","unstructured":"Fasth, A. E. et al. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J. Immunol. 183, 4792\u20134799 (2009).","journal-title":"J. Immunol."},{"key":"BFnrrheum201139_CR17","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1002\/art.27665","volume":"62","author":"JM Pandya","year":"2010","unstructured":"Pandya, J. M. et al. Expanded TCR-V\u03b2 restricted T cells from sporadic inclusion body myositis patients are proinflammatory and cytotoxic CD28(null) T cells. Arthritis Rheum. 62, 3457\u20133466 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/eji.200939399","volume":"40","author":"AE Fasth","year":"2010","unstructured":"Fasth, A. E., Bjorkstrom, N. K., Anthoni, M., Malmberg, K. J. & Malmstrom, V. Activating NK-cell receptors co-stimulate CD4(+)CD28(\u2013) T cells in patients with rheumatoid arthritis. Eur. J. Immunol. 40, 378\u2013387 (2010).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum201139_CR19","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nature07036","volume":"453","author":"E Bettelli","year":"2008","unstructured":"Bettelli, E., Korn, T., Oukka, M. & Kuchroo, V. K. Induction and effector functions of T(H)17 cells. Nature 453, 1051\u20131057 (2008).","journal-title":"Nature"},{"key":"BFnrrheum201139_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0002-9440(10)63131-8","volume":"164","author":"G Page","year":"2004","unstructured":"Page, G. et al. Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression. Am. J. Pathol. 164, 409\u2013417 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201139_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0165-5728(03)00032-8","volume":"137","author":"G Chevrel","year":"2003","unstructured":"Chevrel, G. et al. Interleukin-17 increases the effects of IL-1\u03b2 on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J. Neuroimmunol. 137, 125\u2013133 (2003).","journal-title":"J. Neuroimmunol."},{"key":"BFnrrheum201139_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneuroim.2010.03.013","volume":"225","author":"A Waschbisch","year":"2010","unstructured":"Waschbisch, A., Schwab, N., Ruck, T., Stenner, M. P. & Wiendl, H. FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. J. Neuroimmunol. 225, 137\u2013142 (2010).","journal-title":"J. Neuroimmunol."},{"key":"BFnrrheum201139_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/08916930802282651","volume":"42","author":"L Banica","year":"2009","unstructured":"Banica, L. et al. Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 42, 41\u201349 (2009).","journal-title":"Autoimmunity"},{"key":"BFnrrheum201139_CR24","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","volume":"65","author":"SA Greenberg","year":"2005","unstructured":"Greenberg, S. A. et al. Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 65, 1782\u20131787 (2005).","journal-title":"Neurology"},{"key":"BFnrrheum201139_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0960-8966(96)00015-6","volume":"6","author":"JL De Bleecker","year":"1996","unstructured":"De Bleecker, J. L., Engel, A. G. & Butcher, E. C. Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies. Neuromuscul. Disord. 6, 255\u2013260 (1996).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrrheum201139_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","volume":"178","author":"EM Bradshaw","year":"2007","unstructured":"Bradshaw, E. M. et al. A local antigen-driven humoral response is present in the inflammatory myopathies. J. Immunol. 178, 547\u2013556 (2007).","journal-title":"J. Immunol."},{"key":"BFnrrheum201139_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"TD Levine","year":"2005","unstructured":"Levine, T. D. Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum. 52, 601\u2013607 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/RHU.0b013e3181bb8e70","volume":"15","author":"S Majmudar","year":"2009","unstructured":"Majmudar, S., Hall, H. A. & Zimmermann, B. Treatment of adult inflammatory myositis with rituximab: an emerging therapy for refractory patients. J. Clin. Rheumatol. 15, 338\u2013340 (2009).","journal-title":"J. Clin. Rheumatol."},{"key":"BFnrrheum201139_CR29","first-page":"1009","volume":"27","author":"R Rios Fernandez","year":"2009","unstructured":"Rios Fernandez, R., Callejas Rubio, J. L., Sanchez Cano, D., Saez Moreno, J. A. & Ortego Centeno, N. Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature. Clin. Exp. Rheumatol. 27, 1009\u20131016 (2009).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201139_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jbspin.2007.10.010","volume":"75","author":"A Tournadre","year":"2008","unstructured":"Tournadre, A. et al. Polymyositis and pemphigus vulgaris in a patient: successful treatment with rituximab. Joint Bone Spine 75, 728\u2013729 (2008).","journal-title":"Joint Bone Spine"},{"key":"BFnrrheum201139_CR31","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00296-009-0859-x","volume":"29","author":"E Vandenbroucke","year":"2009","unstructured":"Vandenbroucke, E. et al. Rituximab in life threatening antisynthetase syndrome. Rheumatol. Int. 29, 1499\u20131502 (2009).","journal-title":"Rheumatol. Int."},{"key":"BFnrrheum201139_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/art.11428","volume":"50","author":"G Page","year":"2004","unstructured":"Page, G., Chevrel, G. & Miossec, P. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum. 50, 199\u2013208 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR33","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1002\/art.22860","volume":"56","author":"ML Eloranta","year":"2007","unstructured":"Eloranta, M. L. et al. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies. Arthritis Rheum. 56, 3112\u20133124 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR34","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.20464","volume":"57","author":"SA Greenberg","year":"2005","unstructured":"Greenberg, S. A. et al. Interferon \u03b1\/\u03b2-mediated innate immune mechanisms in dermatomyositis. Ann. Neurol. 57, 664\u2013678 (2005).","journal-title":"Ann. Neurol."},{"key":"BFnrrheum201139_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1600-0560.2007.00848.x","volume":"35","author":"JM McNiff","year":"2008","unstructured":"McNiff, J. M. & Kaplan, D. H. Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus. J. Cutan. Pathol. 35, 452\u2013456 (2008).","journal-title":"J. Cutan. Pathol."},{"key":"BFnrrheum201139_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1365-2990.2004.00591.x","volume":"31","author":"M Civatte","year":"2005","unstructured":"Civatte, M. et al. Expression of the \u03b2 chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies. Neuropathol. Appl. Neurobiol. 31, 70\u201379 (2005).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrrheum201139_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/jnen\/59.2.164","volume":"59","author":"P Confalonieri","year":"2000","unstructured":"Confalonieri, P. et al. Increased expression of \u03b2-chemokines in muscle of patients with inflammatory myopathies. J. Neuropathol. Exp. Neurol. 59, 164\u2013169 (2000).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrrheum201139_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/mus.20294","volume":"31","author":"B De Paepe","year":"2005","unstructured":"De Paepe, B. & De Bleecker, J. L. \u03b2-Chemokine receptor expression in idiopathic inflammatory myopathies. Muscle Nerve 31, 621\u2013627 (2005).","journal-title":"Muscle Nerve"},{"key":"BFnrrheum201139_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/mus.20088","volume":"30","author":"KM Rostasy","year":"2004","unstructured":"Rostasy, K. M. et al. Monocyte\/macrophage differentiation in dermatomyositis and polymyositis. Muscle Nerve 30, 225\u2013230 (2004).","journal-title":"Muscle Nerve"},{"key":"BFnrrheum201139_CR40","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1002\/art.22865","volume":"56","author":"KB Stone","year":"2007","unstructured":"Stone, K. B. et al. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum. 56, 3125\u20133131 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer, R. et al. Autoantibody profiles in the sera of European patients with myositis. Ann. Rheum. Dis. 60, 116\u2013123 (2001).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201139_CR42","first-page":"195","volume":"86","author":"R Mahouachi","year":"2008","unstructured":"Mahouachi, R. et al. Antisynthetase syndrome [French]. Tunis Med. 86, 195\u2013196 (2008).","journal-title":"Tunis Med."},{"key":"BFnrrheum201139_CR43","first-page":"2675","volume":"3","author":"AS Jordan Greco","year":"2007","unstructured":"Jordan Greco, A. S., M\u00e9trailler, J. C. & Dayer, E. The antisynthetase syndrome: a cause of rapidly progressive interstitial lung disease. Rev. Med. Suisse 3, 2675\u20132676, 2679\u20132681 (2007).","journal-title":"Rev. Med. Suisse"},{"key":"BFnrrheum201139_CR44","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1196\/annals.1398.047","volume":"1109","author":"E Gomard-Mennesson","year":"2007","unstructured":"Gomard-Mennesson, E. et al. Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies. Ann. NY Acad. Sci. 1109, 414\u2013420 (2007).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrrheum201139_CR45","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s00108-005-1496-4","volume":"46","author":"E Genth","year":"2005","unstructured":"Genth, E. Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis [German]. Internist (Berl.) 46, 1218\u20131232 (2005).","journal-title":"Internist (Berl.)"},{"key":"BFnrrheum201139_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0248-8663(01)00552-5","volume":"23","author":"L Legout","year":"2002","unstructured":"Legout, L. et al. The antisynthetase syndrome: a subgroup of inflammatory myopathies not to be unrecognized [French]. Rev. Med. Interne 23, 273\u2013282 (2002).","journal-title":"Rev. Med. Interne"},{"key":"BFnrrheum201139_CR47","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1002\/art.24977","volume":"60","author":"AL Mammen","year":"2009","unstructured":"Mammen, A. L. et al. Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle. Arthritis Rheum. 60, 3784\u20133793 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","volume":"46","author":"K Kaji","year":"2007","unstructured":"Kaji, K. et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford) 46, 25\u201328 (2007).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201139_CR49","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff, I. N. et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 54, 3682\u20133689 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR50","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato, S. et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 60, 2193\u20132200 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR51","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1002\/art.22790","volume":"56","author":"SM Levine","year":"2007","unstructured":"Levine, S. M. et al. Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum. 56, 2729\u20132739 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR52","doi-asserted-by":"crossref","unstructured":"Soejima, M. et al. Role of innate immunity in a model of histidyl-tRNA synthetase (Jo-1)-mediated myositis. Arthritis Rheum. (2010).","DOI":"10.1002\/art.30113"},{"key":"BFnrrheum201139_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jaut.2007.07.005","volume":"29","author":"Y Katsumata","year":"2007","unstructured":"Katsumata, Y. et al. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J. Autoimmun. 29, 174\u2013186 (2007).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum201139_CR54","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/art.21893","volume":"54","author":"T Lovgren","year":"2006","unstructured":"Lovgren, T. et al. Induction of interferon-\u03b1 by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sj\u00f6gren's syndrome autoantigen-associated RNA. Arthritis Rheum. 54, 1917\u20131927 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR55","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1002\/art.24683","volume":"60","author":"S Barbasso Helmers","year":"2009","unstructured":"Barbasso Helmers, S. et al. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells. Arthritis Rheum. 60, 2524\u20132530 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR56","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/art.22388","volume":"56","author":"C Grundtman","year":"2007","unstructured":"Grundtman, C. et al. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. Arthritis Rheum. 56, 674\u2013687 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR57","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/art.1780400514","volume":"40","author":"I Lundberg","year":"1997","unstructured":"Lundberg, I., Ulfgren, A. K., Nyberg, P., Andersson, U. & Klareskog, L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40, 865\u2013874 (1997).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR58","first-page":"419","volume":"19","author":"BA St. Pierre","year":"1992","unstructured":"St. Pierre, B. A., Kasper, C. E. & Lindsey, A. M. Fatigue mechanisms in patients with cancer: effects of tumor necrosis factor and exercise on skeletal muscle. Oncol. Nurs. Forum 19, 419\u2013425 (1992).","journal-title":"Oncol. Nurs. Forum"},{"key":"BFnrrheum201139_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0022-510X(96)00280-8","volume":"146","author":"M Tateyama","year":"1997","unstructured":"Tateyama, M. et al. Expression of tumor necrosis factor-\u03b1 in muscles of polymyositis. J. Neurol. Sci. 146, 45\u201351 (1997).","journal-title":"J. Neurol. Sci."},{"key":"BFnrrheum201139_CR60","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1136\/ard.2008.091405","volume":"68","author":"O Krystufkova","year":"2009","unstructured":"Krystufkova, O. et al. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Ann. Rheum. Dis. 68, 836\u2013843 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201139_CR61","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1002\/art.22928","volume":"56","author":"RJ Walsh","year":"2007","unstructured":"Walsh, R. J. et al. Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum. 56, 3784\u20133792 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2007.11.011","volume":"7","author":"AL Serrano","year":"2008","unstructured":"Serrano, A. L., Baeza-Raja, B., Perdiguero, E., Jardi, M. & Munoz-Canoves, P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell. Metab. 7, 33\u201344 (2008).","journal-title":"Cell. Metab."},{"key":"BFnrrheum201139_CR63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneuroim.2006.03.026","volume":"176","author":"F Scuderi","year":"2006","unstructured":"Scuderi, F., Mannella, F., Marino, M., Provenzano, C. & Bartoccioni, E. IL-6-deficient mice show impaired inflammatory response in a model of myosin-induced experimental myositis. J. Neuroimmunol 176, 9\u201315 (2006).","journal-title":"J. Neuroimmunol"},{"key":"BFnrrheum201139_CR64","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/intimm\/dxf062","volume":"14","author":"T Sugiura","year":"2002","unstructured":"Sugiura, T. et al. Increased IL-15 production of muscle cells in polymyositis and dermatomyositis. Int. Immunol. 14, 917\u2013924 (2002).","journal-title":"Int. Immunol."},{"key":"BFnrrheum201139_CR65","first-page":"2389","volume":"28","author":"J Suzuki","year":"2001","unstructured":"Suzuki, J. et al. Serum levels of interleukin 15 in patients with rheumatic diseases. J. Rheumatol. 28, 2389\u20132391 (2001).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201139_CR66","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.4049\/jimmunol.177.11.7802","volume":"177","author":"WK Chiu","year":"2006","unstructured":"Chiu, W. K., Fann, M. & Weng, N. P. Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines. J. Immunol. 177, 7802\u20137810 (2006).","journal-title":"J. Immunol."},{"key":"BFnrrheum201139_CR67","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S1065-6995(03)00172-0","volume":"27","author":"PS Furmanczyk","year":"2003","unstructured":"Furmanczyk, P. S. & Quinn, L. S. Interleukin-15 increases myosin accretion in human skeletal myogenic cultures. Cell Biol. Int. 27, 845\u2013851 (2003).","journal-title":"Cell Biol. Int."},{"key":"BFnrrheum201139_CR68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbagrm.2009.11.003","volume":"1799","author":"U Andersson","year":"2010","unstructured":"Andersson, U. & Harris, H. E. The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim. Biophys. Acta 1799, 141\u2013148 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrrheum201139_CR69","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/art.11161","volume":"48","author":"R Kokkola","year":"2003","unstructured":"Kokkola, R. et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48, 2052\u20132058 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ncprheum0379","volume":"3","author":"W Jiang","year":"2007","unstructured":"Jiang, W. & Pisetsky, D. S. Mechanisms of disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 3, 52\u201358 (2007).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"BFnrrheum201139_CR71","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/art.20220","volume":"50","author":"AK Ulfgren","year":"2004","unstructured":"Ulfgren, A. K. et al. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum. 50, 1586\u20131594 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR72","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1096\/fj.09-144782","volume":"24","author":"C Grundtman","year":"2010","unstructured":"Grundtman, C. et al. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J. 24, 570\u2013578 (2010).","journal-title":"FASEB J."},{"issue":"Suppl.","key":"BFnrrheum201139_CR73","first-page":"S307","volume":"60","author":"H Alexanderson","year":"2009","unstructured":"Alexanderson, H. et al. Patients with idiopathic inflammatory myopathies have low muscle endurance rather than low muscle strength [abstract 823]. Arthritis Rheum. 60 (Suppl.), S307 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR74","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.410270402","volume":"27","author":"AM Emslie-Smith","year":"1990","unstructured":"Emslie-Smith, A. M. & Engel, A. G. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann. Neurol. 27, 343\u2013356 (1990).","journal-title":"Ann. Neurol."},{"key":"BFnrrheum201139_CR75","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/0046-8177(92)90400-W","volume":"23","author":"R Estruch","year":"1992","unstructured":"Estruch, R. et al. Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum. Pathol. 23, 888\u2013895 (1992).","journal-title":"Hum. Pathol."},{"key":"BFnrrheum201139_CR76","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1002\/art.23884","volume":"58","author":"C Grundtman","year":"2008","unstructured":"Grundtman, C., Tham, E., Ulfgren, A. K. & Lundberg, I. E. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Arthritis Rheum. 58, 3224\u20133238 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR77","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.nmd.2010.01.005","volume":"20","author":"S Probst-Cousin","year":"2010","unstructured":"Probst-Cousin, S., Neundorfer, B. & Heuss, D. Microvasculopathic neuromuscular diseases: lessons from hypoxia-inducible factors. Neuromuscul. Disord. 20, 192\u2013197 (2010).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrrheum201139_CR78","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/art.22996","volume":"57","author":"M Dastmalchi","year":"2007","unstructured":"Dastmalchi, M. et al. Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Rheum. 57, 1303\u20131310 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR79","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2119\/molmed.2010.00016","volume":"16","author":"GA Nader","year":"2010","unstructured":"Nader, G. A. et al. A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis. Mol. Med. 16, 455\u2013464 (2010).","journal-title":"Mol. Med."},{"key":"BFnrrheum201139_CR80","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/art.1780380111","volume":"38","author":"JH Park","year":"1995","unstructured":"Park, J. H. et al. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum. 38, 68\u201377 (1995).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR81","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1002\/art.23729","volume":"58","author":"T Hamada","year":"2008","unstructured":"Hamada, T. et al. Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis. Arthritis Rheum. 58, 2675\u20132685 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR82","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nrd2755","volume":"7","author":"I Kim","year":"2008","unstructured":"Kim, I., Xu, W. & Reed, J. C. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7, 1013\u20131030 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrrheum201139_CR83","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/CS20080680","volume":"118","author":"T Hosoi","year":"2010","unstructured":"Hosoi, T. & Ozawa, K. Endoplasmic reticulum stress in disease: mechanisms and therapeutic opportunities. Clin. Sci. (Lond.) 118, 19\u201329 (2010).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrrheum201139_CR84","doi-asserted-by":"publisher","first-page":"e1609","DOI":"10.1371\/journal.pone.0001609","volume":"3","author":"A Delaunay","year":"2008","unstructured":"Delaunay, A. et al. The ER-bound RING finger protein 5 (RNF5\/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis. PLoS ONE 3, e1609 (2008).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201139_CR85","first-page":"136","volume":"75","author":"J van der Pas","year":"2004","unstructured":"van der Pas, J., Hengstman, G. J., ter Laak, H. J., Borm, G. F. & van Engelen, B. G. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J. Neurol. Neurosurg. Psychiatry 75, 136\u2013139 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrrheum201139_CR86","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/mus.21129","volume":"39","author":"S Salomonsson","year":"2009","unstructured":"Salomonsson, S. et al. Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle. Muscle Nerve 39, 674\u2013682 (2009).","journal-title":"Muscle Nerve"},{"key":"BFnrrheum201139_CR87","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/BOR.0b013e3283319265","volume":"21","author":"A Henriques-Pons","year":"2009","unstructured":"Henriques-Pons, A. & Nagaraju, K. Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis. Curr. Opin. Rheumatol. 21, 581\u2013587 (2009).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201139_CR88","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1750-3639.2009.00290.x","volume":"19","author":"V Askanas","year":"2009","unstructured":"Askanas, V., Engel, W. K. & Nogalska, A. Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation. Brain Pathol. 19, 493\u2013506 (2009).","journal-title":"Brain Pathol."},{"key":"BFnrrheum201139_CR89","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.164.10.5459","volume":"164","author":"K Nagaraju","year":"2000","unstructured":"Nagaraju, K. et al. The inhibition of apoptosis in myositis and in normal muscle cells. J. Immunol. 164, 5459\u20135465 (2000).","journal-title":"J. Immunol."},{"key":"BFnrrheum201139_CR90","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.neurobiolaging.2008.11.003","volume":"31","author":"A Shtifman","year":"2010","unstructured":"Shtifman, A. et al. Amyloid-\u03b2 protein impairs Ca(2+) release and contractility in skeletal muscle. Neurobiol. Aging 31, 2080\u20132090 (2010).","journal-title":"Neurobiol. Aging"},{"key":"BFnrrheum201139_CR91","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jns.2008.11.010","volume":"278","author":"P Temiz","year":"2009","unstructured":"Temiz, P., Weihl, C. C. & Pestronk, A. Inflammatory myopathies with mitochondrial pathology and protein aggregates. J. Neurol. Sci. 278, 25\u201329 (2009).","journal-title":"J. Neurol. Sci."},{"key":"BFnrrheum201139_CR92","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.2353\/ajpath.2010.100050","volume":"177","author":"A Nogalska","year":"2010","unstructured":"Nogalska, A., D'Agostino, C., Terracciano, C., Engel, W. K. & Askanas, V. Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers. Am. J. Pathol. 177, 1377\u20131387 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201139_CR93","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292, 344\u2013347 (1975).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201139_CR94","first-page":"668","volume":"22","author":"K Tanimoto","year":"1995","unstructured":"Tanimoto, K. et al. Classification criteria for polymyositis and dermatomyositis. J. Rheumatol. 22, 668\u2013674 (1995).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201139_CR95","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk, J. E. et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands. Neuromuscul. Disord. 14, 337\u2013345 (2004).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrrheum201139_CR96","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0046-8177(86)80180-0","volume":"17","author":"AG Engel","year":"1986","unstructured":"Engel, A. G. & Arahata, K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum. Pathol. 17, 704\u2013721 (1986).","journal-title":"Hum. Pathol."},{"key":"BFnrrheum201139_CR97","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ana.410190203","volume":"19","author":"K Arahata","year":"1986","unstructured":"Arahata, K. & Engel, A. G. Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann. Neurol. 19, 112\u2013125 (1986).","journal-title":"Ann. Neurol."},{"key":"BFnrrheum201139_CR98","unstructured":"National Institue of Environmental Health Sciences. International Myositis Assessment and Clinical Research (IMACS) [online] , (2011)."},{"key":"BFnrrheum201139_CR99","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","volume":"6","author":"MC Dalakas","year":"2010","unstructured":"Dalakas, M. C. Immunotherapy of myositis: issues, concerns and future prospects. Nat. Rev. Rheumatol. 6, 129\u2013137 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum201139_CR100","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/030097400750001897","volume":"29","author":"J Vencovsky","year":"2000","unstructured":"Vencovsky, J. et al. Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand. J. Rheumatol. 29, 95\u2013102 (2000).","journal-title":"Scand. J. Rheumatol."},{"key":"BFnrrheum201139_CR101","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s10067-006-0526-5","volume":"26","author":"P Caramaschi","year":"2007","unstructured":"Caramaschi, P., Volpe, A., Carletto, A., Bambara, L. M. & Biasi, D. Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature. Clin. Rheumatol. 26, 1795\u20131796 (2007).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum201139_CR102","first-page":"1542","volume":"27","author":"AC Gelber","year":"2000","unstructured":"Gelber, A. C., Nousari, H. C. & Wigley, F. M. Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases. J. Rheumatol 27, 1542\u20131545 (2000).","journal-title":"J. Rheumatol"},{"key":"BFnrrheum201139_CR103","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1157\/13102329","volume":"207","author":"A L\u00f3pez de la Osa","year":"2007","unstructured":"L\u00f3pez de la Osa, A., S\u00e1nchez Tapia, C., Arias D\u00edaz, M. & Terrancle de Juan, I. Antisynthetase syndrome with good response to mycophenolate mofetil [Spanish]. Rev. Clin. Esp. 207, 269\u2013270 (2007).","journal-title":"Rev. Clin. Esp."},{"key":"BFnrrheum201139_CR104","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas, M. C. et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N. Engl. J. Med. 329, 1993\u20132000 (1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201139_CR105","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1136\/ard.2006.058644","volume":"66","author":"S Barbasso Helmers","year":"2007","unstructured":"Barbasso Helmers, S. et al. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann. Rheum. Dis. 66, 1276\u20131283 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201139_CR106","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1002\/art.21240","volume":"52","author":"MR Wilkes","year":"2005","unstructured":"Wilkes, M. R., Sereika, S. M., Fertig, N., Lucas, M. R. & Oddis, C. V. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum. 52, 2439\u20132446 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR107","doi-asserted-by":"crossref","unstructured":"Haroon, M. & Devlin, J. Rituximab as a first-line agent for the treatment of dermatomyositis. Rheumatol. Int. doi:10.1007\/S00296-010-1458-6.","DOI":"10.1007\/s00296-010-1458-6"},{"key":"BFnrrheum201139_CR108","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jbspin.2007.07.010","volume":"75","author":"A Furlan","year":"2008","unstructured":"Furlan, A., Botsios, C., Ruffatti, A., Todesco, S. & Punzi, L. Antisynthetase syndrome with refractory polyarthritis and fever successfully treated with the IL-1 receptor antagonist, anakinra: A case report. Joint Bone Spine 75, 366\u2013367 (2008).","journal-title":"Joint Bone Spine"},{"issue":"Suppl.","key":"BFnrrheum201139_CR109","first-page":"S218","volume":"60","author":"C Dorph","year":"2009","unstructured":"Dorph, C. et al. Anakinra in patients with refractory idiopathic inflammatory myopathies [abstract 589]. Arthritis Rheum. 60 (Suppl.) S218 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR110","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1136\/ard.2007.077974","volume":"67","author":"M Dastmalchi","year":"2008","unstructured":"Dastmalchi, M. et al. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Ann. Rheum. Dis. 67, 1670\u20131677 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201139_CR111","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/BOR.0b013e328324e700","volume":"21","author":"H Alexanderson","year":"2009","unstructured":"Alexanderson, H. Exercise effects in patients with adult idiopathic inflammatory myopathies. Curr. Opin. Rheumatol. 21, 158\u2013163 (2009).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201139_CR112","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/art.22780","volume":"57","author":"H Alexanderson","year":"2007","unstructured":"Alexanderson, H., Dastmalchi, M., Esbjornsson-Liljedahl, M., Opava, C. H. & Lundberg, I. E. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum. 57, 768\u2013777 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201139_CR113","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.autrev.2008.11.008","volume":"8","author":"V de Salles Painelli","year":"2009","unstructured":"de Salles Painelli, V. et al. The possible role of physical exercise on the treatment of idiopathic inflammatory myopathies. Autoimmun. Rev. 8, 355\u2013359 (2009).","journal-title":"Autoimmun. Rev."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2011.39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2011.39","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2011.39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T03:55:48Z","timestamp":1686023748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2011.39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,5]]},"references-count":113,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["BFnrrheum201139"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2011.39","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,5]]}}}